Publications in International Peer-Reviewed Journals

(2026). Trends in Polypharmacy Among Patients With Atrial Fibrillation: A Report From the Finnish AntiCoagulation in Atrial Fibrillation Nationwide Cohort Study. J Am Heart Assoc.
(2026). Machine Learning-Based Prediction of Drug-Induced QTc Changes in a Large Finnish Biobank Cohort. Clin Transl Sci (submitted).
(2025). Associations between gut microbiome and circulating cytokines: a cross-sectional analysis in the FINRISK 2002 population cohort. Gut Pathog.
(2025). Venous thromboembolisms and stroke risk in patients with atrial fibrillation: a nationwide cohort study. Europace.
(2025). Heart Failure and Stroke Risk in Atrial Fibrillation: Temporal Trends From a Nationwide Cohort Study. J Am Heart Assoc.
(2025). Effects of Cholinesterase Inhibitor Medication on QTc Interval in Memory Clinic Patients. Ann Pharmacother.
(2025). Net Benefit of Anticoagulation in Subclinical Device-Detected Atrial Fibrillation. JAMA Netw Open.
(2025). Association between educational attainment and blood pressure in older adults: a study of two Finnish generational cohorts born 20 years apart. Int J Cardiol Cardiovasc Risk Prev.
(2025). Clinical outcomes of atrial fibrillation screening: a meta-analysis of randomized controlled trials. Ann Med.